NCT03493451 2024-10-26Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell NeoplasmsBeiGenePhase 2 Completed77 enrolled 20 charts
NCT02273739 2021-02-23Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCelgenePhase 1/2 Completed21 enrolled 33 charts
NCT00293488 2016-06-23SL-11047 in Treating Patients With Relapsed or Refractory LymphomaProgen PharmaceuticalsPhase 1 Completed20 enrolled
NCT01748721 2016-01-08MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaMorphotekPhase 1 Completed27 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts